As of 2025-04-23, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.16 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of BetterLife Pharma Inc is -275.39%.
Based on its market price of 0.09 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 275.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.16 - -0.16 | -0.16 | -275.39% |
| DDM - Stable | (0.32) - (5.12) | (2.72) | -3122.6% |
| DDM - Multi | (0.92) - (11.77) | (1.73) | -2018.9% |
| Market Cap (mil) | 11.65 |
| Beta | -0.42 |
| Outstanding shares (mil) | 129.46 |
| Enterprise Value (mil) | 12.49 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.71% |
| Cost of Debt | 5.00% |
| WACC | 7.43% |